[Congressional Record Volume 167, Number 88 (Thursday, May 20, 2021)]
[Senate]
[Page S3265]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]
SA 1838. Mr. RISCH submitted an amendment intended to be proposed to
amendment SA 1502 proposed by Mr. Schumer to the bill S. 1260, to
establish a new Directorate for Technology and Innovation in the
National Science Foundation, to establish a regional technology hub
program, to require a strategy and report on economic security,
science, research, innovation, manufacturing, and job creation, to
establish a critical supply chain resiliency program, and for other
purposes; which was ordered to lie on the table; as follows:
At the appropriate place in title III of division F,
insert the following:
SEC. 63__. PROHIBITION ON SHARING OF INFORMATION RELATING TO
THE MANUFACTURE OF VACCINES.
(a) In General.--No manufacturer of a vaccine, including
any vaccine related to the SARS-CoV-2 virus, that was
developed in whole or in part with the support of Federal
funds may enter into an agreement to share or provide any
intellectual property, procedure, machinery, or material for
the manufacture of such vaccine with an entity in a foreign
country unless the President of the United States certifies
that--
(1) the foreign country is a signatory to, and in full
compliance with, the Biological Weapons Convention; and
(2) the entity in a foreign country that would be a
recipient of such intellectual property, procedure,
machinery, or material for the manufacture of a vaccine fully
complies with the requirements of the Food and Drug
Administration or equivalent requirements and procedures for
determining the safety and efficacy of vaccines.
(b) Biological Weapons Convention.--In this section, the
term ``Biological Weapons Convention'' means the Convention
on the Prohibition of the Development, Production and
Stockpiling of Bacteriological and Toxin Weapons and on their
Destruction, done at Washington, London, and Moscow, April
10, 1972.
______